| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,297 |
12,952 |
$2.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,685 |
3,098 |
$1.32M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,535 |
12,883 |
$1.31M |
| 80053 |
Comprehensive metabolic panel |
28,395 |
22,928 |
$678K |
| 36415 |
Collection of venous blood by venipuncture |
35,705 |
25,635 |
$658K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,939 |
22,062 |
$514K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,967 |
1,670 |
$506K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
533 |
468 |
$414K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,141 |
7,636 |
$373K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,614 |
1,397 |
$351K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,346 |
5,820 |
$310K |
| G0378 |
Hospital observation service, per hour |
2,872 |
1,467 |
$299K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,201 |
2,574 |
$298K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,299 |
2,794 |
$254K |
| 85027 |
|
10,091 |
8,140 |
$230K |
| 84703 |
|
3,913 |
3,362 |
$202K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,357 |
9,451 |
$193K |
| 84484 |
|
6,869 |
5,113 |
$191K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,360 |
1,194 |
$191K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,716 |
3,120 |
$182K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,168 |
4,415 |
$180K |
| 83735 |
|
7,865 |
5,384 |
$178K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,491 |
5,022 |
$175K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,572 |
5,197 |
$169K |
| 81001 |
|
12,233 |
10,286 |
$162K |
| 82962 |
|
3,661 |
2,156 |
$159K |
| 83690 |
|
5,198 |
4,369 |
$153K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,486 |
1,752 |
$151K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,165 |
5,466 |
$142K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,557 |
8,944 |
$139K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,010 |
1,735 |
$132K |
| 71045 |
Radiologic examination, chest; single view |
5,589 |
4,757 |
$128K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,362 |
1,273 |
$117K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,767 |
5,021 |
$115K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
912 |
836 |
$104K |
| 87088 |
|
4,844 |
4,241 |
$104K |
| 85610 |
|
4,778 |
3,939 |
$102K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
226 |
117 |
$102K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,995 |
2,783 |
$101K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,897 |
2,696 |
$100K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
423 |
382 |
$92K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,490 |
2,635 |
$88K |
| 71046 |
Radiologic examination, chest; 2 views |
1,834 |
1,644 |
$86K |
| 85730 |
|
3,891 |
3,195 |
$86K |
| 81003 |
|
2,675 |
2,455 |
$81K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,108 |
977 |
$80K |
| 86850 |
|
3,504 |
3,080 |
$76K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,513 |
1,379 |
$72K |
| 87631 |
|
562 |
508 |
$71K |
| 80061 |
Lipid panel |
4,041 |
3,703 |
$70K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,390 |
2,139 |
$67K |
| 88142 |
|
2,638 |
2,521 |
$62K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,760 |
763 |
$61K |
| 86900 |
|
2,710 |
2,351 |
$60K |
| 83605 |
|
2,738 |
2,253 |
$57K |
| 88300 |
|
363 |
307 |
$56K |
| 87040 |
|
1,301 |
1,100 |
$56K |
| 82150 |
|
688 |
611 |
$55K |
| 82565 |
|
1,307 |
1,131 |
$53K |
| 74018 |
|
910 |
758 |
$53K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
406 |
373 |
$51K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
201 |
182 |
$51K |
| 86901 |
|
2,735 |
2,371 |
$49K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,998 |
2,733 |
$48K |
| 82550 |
|
1,618 |
1,299 |
$47K |
| 88307 |
|
251 |
202 |
$46K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
188 |
172 |
$43K |
| 82553 |
|
653 |
475 |
$41K |
| 87077 |
|
1,927 |
1,682 |
$41K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
968 |
932 |
$39K |
| 84439 |
|
2,733 |
2,408 |
$37K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
210 |
171 |
$37K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,234 |
2,015 |
$37K |
| 93017 |
|
262 |
240 |
$36K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,547 |
1,414 |
$35K |
| 99152 |
|
633 |
578 |
$33K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
415 |
399 |
$33K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,151 |
1,046 |
$32K |
| 87186 |
|
1,629 |
1,422 |
$30K |
| 86803 |
|
1,715 |
1,555 |
$30K |
| 88312 |
|
599 |
533 |
$30K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
417 |
245 |
$27K |
| 96367 |
|
322 |
231 |
$26K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
482 |
271 |
$25K |
| 83880 |
|
1,076 |
892 |
$23K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
16 |
14 |
$23K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
232 |
217 |
$22K |
| 88342 |
|
75 |
68 |
$21K |
| 80050 |
General health panel |
1,259 |
1,099 |
$21K |
| 87340 |
|
1,461 |
1,333 |
$20K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
396 |
345 |
$19K |
| 87150 |
|
483 |
442 |
$18K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,195 |
2,789 |
$17K |
| 84702 |
|
816 |
617 |
$17K |
| 99153 |
Mod sedat endo service >5yrs |
400 |
366 |
$17K |
| 87070 |
|
638 |
553 |
$16K |
| 80329 |
|
851 |
712 |
$15K |
| 86762 |
|
723 |
655 |
$15K |
| 96376 |
|
630 |
372 |
$14K |
| 87641 |
|
266 |
247 |
$14K |
| 86592 |
|
969 |
879 |
$14K |
| 87430 |
|
267 |
233 |
$13K |
| 83615 |
|
342 |
257 |
$13K |
| 93458 |
|
48 |
44 |
$12K |
| 93971 |
|
178 |
160 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
123 |
102 |
$12K |
| 85379 |
|
478 |
424 |
$12K |
| 82607 |
|
885 |
798 |
$11K |
| 85652 |
|
1,030 |
881 |
$10K |
| 71250 |
|
74 |
64 |
$10K |
| 73630 |
|
247 |
202 |
$9K |
| 73564 |
|
88 |
79 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
160 |
138 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
430 |
395 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
338 |
256 |
$7K |
| 86140 |
|
1,148 |
919 |
$7K |
| 81025 |
|
446 |
391 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
3,453 |
2,281 |
$7K |
| 82947 |
|
557 |
507 |
$6K |
| 72110 |
|
89 |
80 |
$6K |
| 88304 |
|
84 |
73 |
$5K |
| 76830 |
Ultrasound, transvaginal |
47 |
42 |
$5K |
| 93296 |
|
559 |
550 |
$5K |
| 82728 |
|
428 |
396 |
$5K |
| 73130 |
|
178 |
117 |
$4K |
| 93880 |
|
26 |
24 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
130 |
114 |
$4K |
| 83540 |
|
503 |
462 |
$4K |
| 0100U |
|
55 |
52 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
117 |
106 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,797 |
1,656 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
130 |
116 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,121 |
3,287 |
$4K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
69 |
60 |
$4K |
| 82378 |
|
79 |
70 |
$4K |
| 76642 |
|
41 |
38 |
$3K |
| 59025 |
Fetal non-stress test |
321 |
216 |
$3K |
| 87481 |
|
127 |
113 |
$3K |
| 86304 |
|
140 |
133 |
$3K |
| 73610 |
|
85 |
71 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
15 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
33 |
$3K |
| 83550 |
|
285 |
257 |
$3K |
| 80143 |
|
228 |
183 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
413 |
294 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
171 |
161 |
$2K |
| 87081 |
|
162 |
152 |
$2K |
| 88112 |
|
13 |
13 |
$2K |
| 86308 |
|
53 |
46 |
$2K |
| 93000 |
|
25 |
21 |
$1K |
| 84550 |
|
66 |
50 |
$1K |
| 73030 |
|
73 |
66 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,245 |
863 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,180 |
930 |
$1K |
| 82784 |
|
90 |
81 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
688 |
545 |
$962.05 |
| 94760 |
|
40 |
27 |
$958.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,208 |
1,821 |
$890.00 |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
13 |
$878.70 |
| 84100 |
|
163 |
133 |
$757.18 |
| 36600 |
|
16 |
13 |
$687.37 |
| 82803 |
|
15 |
12 |
$669.36 |
| T1015 |
Clinic visit/encounter, all-inclusive |
13 |
12 |
$653.17 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
526 |
378 |
$630.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,787 |
2,241 |
$618.82 |
| 86922 |
|
14 |
13 |
$612.66 |
| 84153 |
|
28 |
27 |
$577.79 |
| 84450 |
|
120 |
96 |
$526.22 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
85 |
45 |
$485.92 |
| 83001 |
|
12 |
12 |
$457.75 |
| C1769 |
Guide wire |
915 |
593 |
$450.44 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
35 |
33 |
$415.85 |
| 84460 |
|
98 |
85 |
$413.77 |
| 86038 |
|
47 |
41 |
$393.29 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
14 |
$376.81 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
3,173 |
2,550 |
$364.17 |
| 87076 |
|
43 |
38 |
$354.18 |
| 83516 |
|
15 |
13 |
$352.91 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
15 |
$343.40 |
| 86709 |
|
48 |
42 |
$336.80 |
| 80076 |
|
66 |
59 |
$332.48 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
36 |
29 |
$318.41 |
| 82043 |
|
100 |
87 |
$317.18 |
| 82746 |
|
32 |
29 |
$305.79 |
| 84403 |
|
17 |
16 |
$301.99 |
| 94060 |
|
12 |
12 |
$299.16 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$287.58 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$271.81 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
25 |
25 |
$264.84 |
| 97161 |
|
16 |
12 |
$264.12 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
556 |
424 |
$262.72 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$256.25 |
| 84402 |
|
13 |
12 |
$252.12 |
| 76937 |
|
43 |
40 |
$234.31 |
| 86618 |
|
17 |
13 |
$183.96 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
177 |
120 |
$177.64 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
743 |
342 |
$169.80 |
| 86705 |
|
17 |
16 |
$148.26 |
| 87590 |
|
13 |
13 |
$148.15 |
| 86255 |
|
17 |
14 |
$141.05 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
30 |
26 |
$136.67 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
252 |
207 |
$122.88 |
| 86706 |
|
13 |
12 |
$101.73 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
29 |
24 |
$79.66 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
99 |
67 |
$76.38 |
| 86430 |
|
13 |
12 |
$55.30 |
| 36591 |
|
77 |
57 |
$52.38 |
| 96523 |
|
36 |
25 |
$31.34 |
| J2060 |
Injection, lorazepam, 2 mg |
64 |
48 |
$26.88 |
| 85018 |
|
17 |
13 |
$21.36 |
| 85014 |
|
17 |
13 |
$21.36 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,451 |
1,242 |
$17.17 |
| 85347 |
|
14 |
13 |
$11.55 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
66 |
46 |
$9.53 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,018 |
614 |
$2.90 |
| 81015 |
|
25 |
24 |
$1.09 |
| C9113 |
Injection, pantoprazole sodium, per vial |
166 |
91 |
$0.43 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
626 |
508 |
$0.00 |
| J3490 |
Unclassified drugs |
73 |
53 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
162 |
145 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
31 |
25 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
15 |
14 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
202 |
180 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
22 |
12 |
$0.00 |